Monday, March 28, 2022 9:26 AM EDT
The upcoming trial results are expected to show an excellent safety profile of the drug and perhaps some biomarkers that translate into efficacy.
In this article: IKT
Latest Comments
Bitcoin Futures Arrive
If anything undermines bitcoin its quantuum computing and what people can do with it to break Bitcoin encryption. If China hasn't done it already it is on thier top priority whether users know about it or not.
Benefits Of Free Trade Versus Team Biden’s Protectionism
Trump by far was worse. The trade war was started by him and what hurts the most is taxes on consumer goods. Taxes and regulations on militzry and could be used as military goods on China has thumbs up by the general public and for good reason.
Yes, They Are Coming For The Oil Companies
Is There A Light At The End Of The Tunnel For A COVID-19 Therapeutic?
Heres a recent article I wrote on the topic.
https://talkmarkets.com/content/stocks--equities/vaccine-makers-slump-as-oral-antivirals-begin-to-take-center-stage?post=331568
A $5 Trillion Property Bust In China Has Huge Implications For Commodities
All housing in evry country is inflated and is set to fall. Be prepared even if the srock market is unaffested expact al least a 10-20 decline in real estate.
CytoDyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
Its sad what was done with this stock. It goes to show how any given stock has unknown things and is unpredictable. That said, I am still hopeful and am waiting for traction and positive news.
PLX Upcoming Volatility Creates Opportunity
There is plenty of potential in this small cap. Unfortunately like all the small caps there has been negative sentiment for term for quite some time. Hopefully this will go away along with positive news.
Is There A Light At The End Of The Tunnel For A COVID-19 Therapeutic?
Anne thanks for the question. I'm waiting on solid news due to short speculation that has hurt this stock despite continues progress. It appears the world is becoming aware that they need more that just a vaccine for Covid. Whether CYDY will be part of their solution gives this plenty of upside. Its shocking to see this stock trading where it is.
CytoDyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
I'm unsure whether the recent bump in the stock is a relief rally or up on cancer and other news of theirs. I think the bulls are still waiting for news to sink their teeth into.
Lose Less
Sadly bond rates are so low the upside it vary limited and the risk of inflation growing making them simple losses is growing as well. It's not your regular cycle by no means.